Fujii Masato, Yamashita Taku, Ishiguro Ryuichirou, Tashiro Masatugu, Kameyama Kaori
Department of Otolaryngology, School of Medicine, Keio University, 35 Shinanomachi Shinjuku-ku, 160-8582, Tokyo, Japan.
Auris Nasus Larynx. 2002 Apr;29(2):175-81. doi: 10.1016/s0385-8146(01)00135-3.
The expression of epidermal growth factor receptor (EGFR) is one of the indicators, which can predict the malignant potential of squamous cell carcinoma of the head and neck (HNSCC). On the other hand, previous histological studies have proved tumor-associated tissue eosinophilia (TATE) to be a favorable prognostic indicator for HNSCC. We studied the prognostic significance of co-expression of EGFR and TATE.
We examined the expression of EGFR and TATE in 53 patients with nasopharyngeal carcinoma (NPC). Biopsy specimens were subjected to immunohistochemical-staining for EGFR expression and Luna-staining for TATE. EGFR staining was considered negative when immuno-stained cells were less than 25% in a field. TATE was divided into four grades as grade 0 for 0-2 eosinophils in a high power field, grade 1 for 3-9, grade 2 for 10-29, and grade 3 for 30 or more.
In terms of TATE expression, 27 patients were classified as grade 0, 12 as grade 1, six as grade 2, and eight as grade 3. Forty-four patients were EGFR positive and nine were negative. We found no statistical significance in the distribution of EGFR positivity and TATE grades. Among EGFR-positive patients, 5 year survival rates were significantly better in TATE-positive (grades 1, 2, 3) patients than in TATE-negative (grade 0) patients (P=0.0139).
Eosinophils may be activated in the tumor tissue, in which the expression of EGFR is up-regulated. This suggests that the activated eosinophils in EGFR-positive tumors resulted in better prognoses. TATE infiltration and EGFR expression may be closely related to the malignant potential of NPC, and co-expression of TATE and EGFR may be an important prognostic factor.
表皮生长因子受体(EGFR)的表达是预测头颈部鳞状细胞癌(HNSCC)恶性潜能的指标之一。另一方面,既往组织学研究已证实肿瘤相关组织嗜酸性粒细胞增多(TATE)是HNSCC的一个良好预后指标。我们研究了EGFR和TATE共表达的预后意义。
我们检测了53例鼻咽癌(NPC)患者中EGFR和TATE的表达。活检标本进行EGFR表达的免疫组织化学染色和TATE的卢娜染色。当免疫染色细胞在一个视野中少于25%时,EGFR染色被认为是阴性。TATE分为四个等级,高倍视野中0 - 2个嗜酸性粒细胞为0级,3 - 9个为1级,10 - 29个为2级,30个或更多为3级。
就TATE表达而言,27例患者分类为0级,12例为1级,6例为2级,8例为3级。44例患者EGFR阳性,9例阴性。我们发现EGFR阳性和TATE等级的分布没有统计学意义。在EGFR阳性患者中,TATE阳性(1、2、3级)患者的5年生存率显著高于TATE阴性(0级)患者(P = 0.0139)。
嗜酸性粒细胞可能在EGFR表达上调的肿瘤组织中被激活。这表明EGFR阳性肿瘤中被激活的嗜酸性粒细胞导致了更好的预后。TATE浸润和EGFR表达可能与NPC的恶性潜能密切相关,TATE和EGFR的共表达可能是一个重要的预后因素。